Documento completo  |  Capítulo completo  |  Expandir índice  |  Versión HTML imprimible
Use of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce - EDM Research Series No. 016
(1995; 156 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoACKNOWLEDGMENTS
Ver el documentoPREFACE
Ver el documentoEXECUTIVE SUMMARY
Abrir esta carpeta y ver su contenido1. INTRODUCTION
Ver el documento2. RATIONALE AND OBJECTIVE OF THE ASSESSMENT
Ver el documento3. ACTIVITIES UNDERTAKEN: Preparations and Method of Work
Abrir esta carpeta y ver su contenido4. ANALYSIS OF RESULTS FROM IMPORTING COUNTRIES
Abrir esta carpeta y ver su contenido5. ANALYSIS OF RESULTS FROM EXPORTING COUNTRIES
Ver el documento6. ANALYSIS OF RESULTS FROM INTERNATIONAL SUPPLY AGENCIES
Abrir esta carpeta y ver su contenido7. SUMMARY ANALYSIS
Ver el documento8. CONCLUSIONS
Ver el documentoANNEX 1: Resolution adopted by the Twenty-second World Health Assembly
Ver el documentoANNEX 2 (a): Resolution Adopted by the Twenty-Eighth World Health Assembly
Ver el documentoANNEX 2 (b): Certificate of Pharmaceutical Product(S)1
Ver el documentoANNEX 3 (a): Resolution adopted by the Forty-first World Health Assembly
Ver el documentoANNEX 3 (b): Certificate of Pharmaceutical Product(s)1 (Proposed Layout)
Ver el documentoANNEX 4 (a): Proposed Guidelines on the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce
Ver el documentoANNEX 4 (b): Certificate of a Pharmaceutical Product
Ver el documentoANNEX 4 (c): Statement of Licensing Status of Pharmaceutical Product(s) Model Statement of Licensing Status of Pharmaceutical Product(s)
Ver el documentoANNEX 4 (d): Manufacturer’s/Official Batch Certificate of a Pharmaceutical Product
Ver el documentoANNEX 5: Protocol for the Assessment of the Use of the WHO Certification Scheme by Importing Country
Ver el documentoANNEX 6: List of Participants in the Study
Ver el documentoANNEX 7: Protocol for the Assessment of the Use of the WHO Certification Scheme by Exporting Country
Ver el documentoANNEX 8: Protocol for the Assessment of the Use of the WHO Certification Scheme in an International Supply Organization
Ver el documentoANNEX 9: Study Instrument for Assessment of the WHO Certification Scheme by Importing Country
Abrir esta carpeta y ver su contenidoANNEX 10: Summaries of Mission Reports on the Assessment of the Use of the WHO Certification Scheme
Ver el documentoBACK COVER
 

2. RATIONALE AND OBJECTIVE OF THE ASSESSMENT

During the last two decades WHO has promoted the use of the WHO Certification Scheme particularly by importing countries of the developing world who, for various reasons, may be vulnerable to problems associated with pharmaceutical products that do not meet specifications. These countries often do not have the national laboratories required to verify the quality of drugs.

Since the introduction of the Scheme, there have been important changes in the nature and scope of the international market in pharmaceutical products. Many more countries are now involved in the export of drugs so that there is no longer a limited number of primary sources in a few major industrial countries. In addition, the opportunities for re-packaging and labelling have grown to further complicate the issuance of a Certificate of a Pharmaceutical Product by a national regulatory authority.

It has also become clear that the exact forms of the WHO Certification Scheme, as described above, have not yet been applied to most of the pharmaceutical products moving in international trade. When this is coupled with the serious problems of sub-standard drugs moving in international commerce, particularly to developing countries, it is clearly important to assess the practical application of the Certification Scheme.

The Action Programme on Essential Drugs (DAP), with the financial support of USAID's Office of Health, therefore, decided to carry out an independent assessment of the use of the Certification Scheme in drug procurement/supply systems and current mechanisms of drug quality assurance, in order to examine its effectiveness and enhance its wider use.

Ir a la sección anterior
Ir a la siguiente sección
 
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019